Latest news with #Anthem
Yahoo
an hour ago
- Business
- Yahoo
Curaleaf Expands Florida Footprint with New St. Augustine, Florida Dispensary
New location in Northeast Florida brings store count to 68 statewide and 154 nationwide STAMFORD, Conn., Aug. 1, 2025 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of a new medical cannabis dispensary in St. Augustine, Florida. Curaleaf St. Augustine, located at 1280 Ponce De Leon Blvd., St. Augustine, FL 32084, will begin welcoming medical patients on August 1, 2025. This expansion marks the Company's 68th store in Florida, bringing its nationwide store count to 154 stores. Conveniently located on Ponce de Leon Boulevard just outside the city's historic district, Curaleaf St. Augustine is minutes from downtown shops, dining, and cultural attractions. The dispensary is centrally located, and carries a broad portfolio of medical cannabis products, including Curaleaf's new Grassroots Dark Heart Collection, Select brand vapes and edibles, Florida-exclusive flower brand Reef, Anthem pre-rolls, and other quality, tested products designed to meet the diverse needs of Florida's registered medical cannabis patients. "Our cultivation team has been hard at work developing significant innovations to enhance the flower quality across our brands. I'm thrilled for medical patients in St. Augustine to have access our new flower from Reef, Grassroots and Anthem, that surpasses anything we've seen in the Florida market," said Curaleaf Chairman and CEO Boris Jordan. "As a vertically integrated, medical-only state, we know it's critical to our patients that everything in our cultivation facilities is done with intention across the board. I can proudly say that we're truly delivering craft quality flower at Curaleaf scale, backed by a no-risk guarantee. With our 68th store in the Sunshine State, we are expanding patient access to these trusted, effective products." Coinciding with the launch of Curaleaf's new Grassroots Dark Heart Collection, Curaleaf Florida has introduced a 72-hour Flower Satisfaction Guarantee for premium eighths. Available exclusively to Florida patients who purchase Grassroots and Reef flower eighths, this guarantee reflects Curaleaf's commitment to delivering premium genetics, unrivaled quality, and patient satisfaction. If an eighth of flower purchased from the Grassroots or Reef brand does not meet expectations, patients may return it within 72 hours to the original Curaleaf location for store credit or an exchange. For more information on eligibility and process, patients can contact their local Curaleaf Florida store. Curaleaf St. Augustine will host a grand opening celebration on Friday, August 8, 2025, from 12:00 to 5:00 P.M. ET, featuring giveaways, a Live Lounge livestream featuring Curaleaf's Mt. Dora cultivation leaders, a pre-roll case decorating activation, a ribbon-cutting ceremony, and more. The store will operate from 9:00 A.M. to 8:30 P.M. ET, Monday through Saturday, and 10:00 A.M. to 6 P.M. ET on Sundays. The addition of Curaleaf St. Augustine supports the Company's focus on expanding access to medical cannabis for more Florida patients. For more information on Curaleaf's Florida dispensaries, products, and patient resources, please visit About Curaleaf Holdings Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit Forward Looking Statements This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the opening of a dispensary in St. Augustine, FL. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed on March 3, 2025, which is available under the Company's SEDAR profile at and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release. Contacts: Investor Contact:Curaleaf Holdings, Lyon, Chief Investment OfficerIR@ Media Contact:Curaleaf Holdings, Rahmil, VP Public Relationsmedia@ View original content to download multimedia: SOURCE Curaleaf Holdings, Inc. View original content to download multimedia:
Cision Canada
an hour ago
- Business
- Cision Canada
Curaleaf Expands Florida Footprint with New St. Augustine, Florida Dispensary
STAMFORD, Conn., Aug. 1, 2025 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of a new medical cannabis dispensary in St. Augustine, Florida. Curaleaf St. Augustine, located at 1280 Ponce De Leon Blvd., St. Augustine, FL 32084, will begin welcoming medical patients on August 1, 2025. This expansion marks the Company's 68th store in Florida, bringing its nationwide store count to 154 stores. Conveniently located on Ponce de Leon Boulevard just outside the city's historic district, Curaleaf St. Augustine is minutes from downtown shops, dining, and cultural attractions. The dispensary is centrally located, and carries a broad portfolio of medical cannabis products, including Curaleaf's new Grassroots Dark Heart Collection, Select brand vapes and edibles, Florida-exclusive flower brand Reef, Anthem pre-rolls, and other quality, tested products designed to meet the diverse needs of Florida's registered medical cannabis patients. "Our cultivation team has been hard at work developing significant innovations to enhance the flower quality across our brands. I'm thrilled for medical patients in St. Augustine to have access our new flower from Reef, Grassroots and Anthem, that surpasses anything we've seen in the Florida market," said Curaleaf Chairman and CEO Boris Jordan. "As a vertically integrated, medical-only state, we know it's critical to our patients that everything in our cultivation facilities is done with intention across the board. I can proudly say that we're truly delivering craft quality flower at Curaleaf scale, backed by a no-risk guarantee. With our 68th store in the Sunshine State, we are expanding patient access to these trusted, effective products." Coinciding with the launch of Curaleaf's new Grassroots Dark Heart Collection, Curaleaf Florida has introduced a 72-hour Flower Satisfaction Guarantee for premium eighths. Available exclusively to Florida patients who purchase Grassroots and Reef flower eighths, this guarantee reflects Curaleaf's commitment to delivering premium genetics, unrivaled quality, and patient satisfaction. If an eighth of flower purchased from the Grassroots or Reef brand does not meet expectations, patients may return it within 72 hours to the original Curaleaf location for store credit or an exchange. For more information on eligibility and process, patients can contact their local Curaleaf Florida store. Curaleaf St. Augustine will host a grand opening celebration on Friday, August 8, 2025, from 12:00 to 5:00 P.M. ET, featuring giveaways, a Live Lounge livestream featuring Curaleaf's Mt. Dora cultivation leaders, a pre-roll case decorating activation, a ribbon-cutting ceremony, and more. The store will operate from 9:00 A.M. to 8:30 P.M. ET, Monday through Saturday, and 10:00 A.M. to 6 P.M. ET on Sundays. The addition of Curaleaf St. Augustine supports the Company's focus on expanding access to medical cannabis for more Florida patients. For more information on Curaleaf's Florida dispensaries, products, and patient resources, please visit About Curaleaf Holdings Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit Forward Looking Statements This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the opening of a dispensary in St. Augustine, FL. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed on March 3, 2025, which is available under the Company's SEDAR profile at and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release. Contacts: Investor Contact: Curaleaf Holdings, Inc. Camilo Lyon, Chief Investment Officer [email protected] Media Contact: Curaleaf Holdings, Inc. Jordon Rahmil, VP Public Relations [email protected] SOURCE Curaleaf Holdings, Inc.
CTV News
3 days ago
- Politics
- CTV News
Coquitlam councillors vote to advance development, despite opposition
The debate over density has become a common theme in Metro Vancouver and now a group of Coquitlam residents have taken their fight to city hall. A development in a Coquitlam neighourhood straddling Burnaby is closer to moving ahead following a Monday night vote. Coquitlam city council voted unanimously to give first, second and third readings to a proposal to replace a dozen single-family homes with three buildings – one seven-storey building and two six-storey buildings –near Roy Stibbs Elementary school. One after another, councillors shared their reservations with the project proposed by the developer Anthem, but also expressed concern that if they voted 'no' on Monday, the developer could come back with something larger, which it would be entitled to do. For residents opposing the project, the fact they weren't able to voice their opposition through a public hearing isn't going down well. 'We've had individual councillors come into our neighbourhood, walk around, and us explain to them what our concerns are, and they're all sympathetic, but nobody seems to think there's anything they can do about it,' said Janet Krgovich with the Roy Stibbs Residents group. It's the latest example of frustrations in a municipality over rules imposed by the provincial government, which is aiming to speed up home construction amid record-breaking population growth. 'We need to have the government back off, let us do our own planning, and let us do it the way the community needs to grow, because we were doing a really good job before they stepped in and messed things up for us,' said Cheryl Andrichuk with the Roy Stibbs Residents group. Members of the group had a range of concerns, but insisted it's not about density, stating not enough of the units are intended for families. There are also environmental concerns, which include fears about mature trees being removed. 'The provincial government is talking about calling for transit-oriented development,' said Kathleen Wallace-Deering with the group Protect Coquitlam Urban Forests. 'And what these residents and what we're all saying, is have transit-oriented living. Livable neighbourhoods, healthy urban forest, tree canopy and the right kind of housing – affordable housing.' Ultimately the lack of a public hearing or the sense of meaningful consultation has rubbed the neighbourhood the wrong way. 'We talked to the city planners and they said, well, city council tells us what to do,' Andrichuk said. 'And then we talked to city councillors, and they said, well, the province makes the rules. So we keep going around and around and around in this circle, and we're shut out of this whole process.' On the topic of a public hearing, Coquitlam Mayor Richard Stewart says it's out of his control. 'About 90 per cent of our developments comply with the OCP, the Official Community Plan, and the province has said we're not allowed to hear from the public on those ones, because they believe it will speed [the process],' Stewart told CTV News on Monday. 'These residents have every right to be frustrated, that they don't perceive that council gets to listen – we don't get to listen.' The developer, Anthem, declined an interview but said in a statement it met with residents, even though it had no obligation to do so, noting its proposal was within the limits set out in the community plan. During a public question period session as the meeting stretched into early Tuesday morning, councillor Dennis Marsden responded to comments made by Andrichuk, saying he would send a video of her statement to the provincial government, and raise the issue in September when council hopes to meet with new Housing Minister Christine Boyle.
Yahoo
5 days ago
- Business
- Yahoo
Elevance Health, Inc. (ELV) Downgrades 2025 Earnings Amid Rising Medical Costs
We recently compiled a list of Elevance Health, Inc. stands third on our list among the most undervalued healthcare stocks. Elevance Health, Inc. (NYSE:ELV) is a major U.S. healthcare company, known for its insurance brands Anthem and WellPoint, and its growing Carelon health services arm. It serves around 45.6 million medical plan members and is recognized for integrating technology and value-based care to improve healthcare delivery. The company is facing increased healthcare utilization and rising medical costs, especially in the ACA and Medicaid segments. This has led to a downgrade in full-year 2025 earnings. A 'market-wide morbidity shift' is evident, with new ACA enrollees using emergency services at nearly double the rate of commercial members, and Medicaid patients showing higher acuity due to redeterminations. Amid these challenges, some investors see Elevance Health, Inc. (NYSE:ELV) as one of the most undervalued stocks in the healthcare sector, given its long-term positioning and strategic adjustments. The company expects a surge in elective procedures by Q4 2025 as members act ahead of expiring tax credits in 2026 that could raise their out-of-pocket costs. To address these pressures, the business is ramping up AI-driven tools for risk detection, care coordination, and operational efficiency. It's also expanding value-based care contracts, particularly in behavioral health and oncology, with over one-third of benefit expenses tied to risk-sharing models. The company is adjusting pricing strategies for ACA plans and advocating for Medicaid access amid potential regulatory changes. A healthcare professional discussing a treatment plan with a patient in an outpatient clinic. Though total membership fell by 212,000 in Q2 due to Medicaid attrition, the Medicare Advantage segment continues to grow. Elevance Health, Inc. (NYSE:ELV) is prioritizing long-term financial stability over aggressive member growth as it navigates rising costs, shifting regulations, and post-pandemic care patterns. While we acknowledge the potential of GOOGL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
Yahoo
6 days ago
- Business
- Yahoo
Wells Fargo Cuts Elevance (ELV) Price Target on Margin Uncertainty
Elevance Health, Inc. (NYSE:ELV) ranks among the . Wells Fargo kept its Overweight rating on Elevance Health, Inc. (NYSE:ELV) on July 15, but lowered its price target on the health insurer from $478 to $400. Wells Fargo applied a lower multiple of 10.5x to its 2026 earnings per share projection of $38.05, which is less than the previous multiple of 11.5x. designer491/ Wells Fargo stated that the primary driver of the reduced value multiple was uncertainty regarding margins in the Medicaid, Medicare Advantage (MA), and Health Insurance Exchange (HIX) segments for 2025. The firm also pointed out that there was 'relatively low visibility to improvement in 2026,' especially in the Medicaid and Health Insurance Exchange segments. However, it insisted that Elevance's valuation 'remains compelling once dust settles on estimates.' Elevance Health, Inc. (NYSE:ELV), previously Anthem, Inc., is a leading health-benefits provider in the United States. The company offers medical, pharmaceutical, dental, long-term care, disability, and behavioral health insurance under numerous brands, including Anthem Blue Cross, Blue Shield, Wellpoint, and Carelon. While we acknowledge the potential of ELV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
